BlackRock Updates Passive Stake in Embecta Corp.
Ticker: EMBC · Form: SC 13G/A · Filed: Jan 22, 2024 · CIK: 1872789
| Field | Detail |
|---|---|
| Company | Embecta CORP. (EMBC) |
| Form Type | SC 13G/A |
| Filed Date | Jan 22, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock still owns a chunk of Embecta, signaling continued institutional interest.**
AI Summary
BlackRock Inc. filed an amended Schedule 13G/A on January 22, 2024, indicating its ownership in Embecta Corp. as of December 31, 2023. This filing updates previous disclosures, showing BlackRock's continued significant, but passive, investment in the medical instruments company. This matters to investors because BlackRock is a major institutional investor, and its holdings can signal confidence (or lack thereof) in a company's long-term prospects, even if the specific percentage isn't provided in this excerpt.
Why It Matters
This filing confirms BlackRock's ongoing passive investment in Embecta Corp., which can be a positive signal for other investors due to BlackRock's extensive research capabilities.
Risk Assessment
Risk Level: low — This is a routine update from a large institutional investor and does not indicate any immediate risks or significant changes in company control.
Analyst Insight
An investor should note that BlackRock's continued passive stake suggests a long-term, non-activist investment view, which might be seen as a vote of confidence in Embecta's stability, but doesn't imply any immediate catalysts.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- Embecta Corp. (company) — the subject company in which BlackRock holds shares
- December 31, 2023 (date) — the date of the event requiring the filing
- January 22, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, as stated in the 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G (Amendment No: 3)' sections.
Who is the 'Subject Company' in this filing?
The 'Subject Company' is Embecta Corp., identified by 'COMPANY CONFORMED NAME: Embecta Corp.' and 'Name of Issuer: EMBECTA CORP'.
Who is the 'Filed By' entity in this document?
The 'Filed By' entity is BlackRock Inc., as indicated by 'COMPANY CONFORMED NAME: BlackRock Inc.' under the 'FILED BY' section.
What is the CUSIP Number for the securities mentioned in the filing?
The CUSIP Number for the Common Stock of Embecta Corp. is 29082K105, as stated under 'CUSIP No. 29082K105'.
What was the 'Date of Event Which Requires Filing of this Statement'?
The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, as explicitly stated in the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 22, 2024 regarding Embecta Corp. (EMBC).